News & Blog
Proteins: Translating Structure into Function
ProJenX Announces Formation of Scientific Advisory Board
MEC Portfolio Company Aspen Neuroscience Featured in Wall Street Journal for Parkinson’s Disease Research
WALL STREET JOURNAL: The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure
ENDPOINT NEWS EXCLUSIVE: Sanofi, Astellas venture arms add cash to Avilar’s ‘ATAC’ mission
Looking Ahead Series: Insights on Innovation from the MEC Council and the Brightest Minds
AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS
Medical Excellence Foundation Announces First MERIT Grant
Endpoints News: A stem cell pioneer sent an experiment into space. Patients are the next frontier
Our Sophomore Year: A Review of 2022